These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31564705)

  • 1. [Guillain-Barré syndrome with refractory optic neuropathy].
    Takeuchi Y; Inatomi Y; Nakajima M; Yonehara T
    Rinsho Shinkeigaku; 2019 Oct; 59(10):652-658. PubMed ID: 31564705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Overlap case of Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barré syndrome].
    Shinoda K; Murai H; Shibata K; Samejima S; Kaneto S; Takashima N; Tanaka K
    Rinsho Shinkeigaku; 2012; 52(1):30-3. PubMed ID: 22260976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ataxic form of Guillain-Barré syndrome associated with anti-GD1b IgG antibody].
    Ichikawa H; Susuki K; Yuki N; Kawamura M
    Rinsho Shinkeigaku; 2001 Aug; 41(8):523-5. PubMed ID: 11889840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of Serum IgG Dimer Levels after Treatment with IVIg in Guillain-Barré Syndrome.
    Svačina MKR; Röth P; Bobylev I; Sprenger A; Zhang G; Sheikh KA; Lehmann HC
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):642-648. PubMed ID: 31515689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody.
    Chatani H; Tanaka M; Nagata T; Araki T; Kusunoki S
    J Clin Neurosci; 2014 Jan; 21(1):170-2. PubMed ID: 23916762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case report; A case of anti-GD1b antibody positive pure motor form Guillain-Barré syndrome with good response to combined IVIg and steroid therapy].
    Fujimoto T; Fukuda Y; Eguchi K; Kusunoki S
    Nihon Naika Gakkai Zasshi; 2011 Jun; 100(6):1651-3. PubMed ID: 21770292
    [No Abstract]   [Full Text] [Related]  

  • 7. Polycranial neuropathy and sensory ataxia with IgG anti-GD1a antibody as a variant of Guillain-Barré syndrome.
    Kim SY; Kim JK; Suh CK
    J Clin Neurosci; 2013 Mar; 20(3):473-5. PubMed ID: 23164827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An elderly case of Guillain-Barré syndrome with anti-GT1b antibodies].
    Kinboshi M; Morimoto Y; Yoshida T; Kuzume D; Yamasaki M
    Rinsho Shinkeigaku; 2019 Sep; 59(9):600-603. PubMed ID: 31474642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GQ1b antibody testing in Guillain-Barre syndrome and variants.
    Chaudhry F; Gee KE; Vaphiades MS; Biller J; Jay W
    Semin Ophthalmol; 2006; 21(4):223-7. PubMed ID: 17182410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-GQ1b antibody syndrome presenting with visual deterioration as the initial symptom: A case report.
    Zhao T; Deng Y; Ding Y; Zhang R; Zhou C; Lin W
    Medicine (Baltimore); 2020 Jan; 99(4):e18805. PubMed ID: 31977873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome.
    Yuki N; Susuki K; Hirata K
    Neurology; 2000 May; 54(9):1851-3. PubMed ID: 10802797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete recovery of an aged patient with Guillain-Barré syndrome associated with multiple IgM anti-ganglioside antibodies.
    Furiya Y; Hirano M; Kusunoki S; Ueda M; Sugie K; Nishiwaki T; Ueno S
    Muscle Nerve; 2008 Dec; 38(6):1630-3. PubMed ID: 19016534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fulminant Guillain-Barré syndrome showing severe pharyngeal-cervical-brachial weakness in the recovery phase: a case report.
    Nakamura Y; Motoki M; Hirose T; Hosokawa T; Ishida S; Arawaka S
    BMC Neurol; 2019 Jun; 19(1):145. PubMed ID: 31253118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune-mediated neuropathy].
    Kusunoki S
    Rinsho Shinkeigaku; 2008 Nov; 48(11):1023-5. PubMed ID: 19198151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
    Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
    J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual sensory variant of Guillain-Barré syndrome.
    Semproni M; Gibson G; Kuyper L; Tam P
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28710191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.
    Jacobs BC; O'Hanlon GM; Bullens RW; Veitch J; Plomp JJ; Willison HJ
    Brain; 2003 Oct; 126(Pt 10):2220-34. PubMed ID: 12876146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barré syndrome].
    Lüke C; Dohmen C; Dietlein TS; Brunner R; Lüke M; Krieglstein GK
    Klin Monbl Augenheilkd; 2007 Dec; 224(12):932-4. PubMed ID: 18260057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.